Preetam Shah
2022
In 2022, Preetam Shah earned a total compensation of $683.7K as Chief Financial Officer and Chief Business Officer at Cidara Therapeutics.
Compensation breakdown
Non-Equity Incentive Plan | $151,300 |
---|---|
Option Awards | $54,028 |
Salary | $417,400 |
Stock Awards | $51,836 |
Other | $9,150 |
Total | $683,714 |
Shah received $417.4K in salary, accounting for 61% of the total pay in 2022.
Shah also received $151.3K in non-equity incentive plan, $54K in option awards, $51.8K in stock awards and $9.2K in other compensation.
Rankings
In 2022, Preetam Shah's compensation ranked 3,818th out of 5,753 executives tracked by ExecPay. In other words, Shah earned more than 33.6% of executives.
Classification | Ranking | Percentile |
---|---|---|
All | 3,818 | 34th |
Manufacturing | 2,160 | 31st |
Chemicals And Allied Products | 1,041 | 27th |
Drugs | 977 | 26th |
Biological Products, Except Diagnostic Substances | 229 | 21st |
Shah's colleagues
We found two more compensation records of executives who worked with Preetam Shah at Cidara Therapeutics in 2022.